Skip to content
OpenCapital
Get started

Perspective Therapeutics CATX Indefinite-Lived Intangible Assets

Indefinite-Lived Intangible Assets at other companies

CytomX Therapeutics logo
CytomX TherapeuticsCTMX
$401K-26.7%
Oklo logo
OkloOKLO
——

Other financials

Income statement

See full
Revenue$2.2M+27.3%
Gross profit$738.0K+78.3%
Operating income-$28.3M-29.5%
Net income-$26.2M-44.1%
EPS (diluted)-$0.250.0%

Balance sheet

See full
Cash & equivalents$54.0M+21.5%
Total debt$4.2M+10.9%
Total equity$347.4M+22.1%
Total assets$410.8M+24.7%

Cash flow

See full
Operating cash flow-$31.5M-45.8%
CapEx$6.9M+47.3%
Free cash flow-$38.3M-46.1%

Valuation

See full
Market cap$342.14M+33.2%
Enterprise value$292.34M+35.2%
P/S34.2×+19.6×

Profitability

See full
Gross margin33.1%-7.1pp
Operating margin-292.7%-553pp
Net margin-218.4%-781pp
FCF margin-1,073.3%—

Returns & leverage

See full
Return on equity-35.2%+2.3pp
Debt / equity0×0.0×
Current ratio8.7×-8.3×

Where this comes from

Reported directly by Perspective Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill.

The official record: Perspective Therapeutics’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Perspective Therapeutics's indefinite-lived intangible assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Perspective Therapeutics's indefinite-lived intangible assets?
Perspective Therapeutics (CATX) reported indefinite-lived intangible assets of $40M in Q1 2026.
How has Perspective Therapeutics's indefinite-lived intangible assets changed year-over-year?
Perspective Therapeutics's indefinite-lived intangible assets decreased by 20.0% year-over-year, from $50M to $40M.
What does indefinite-lived intangible assets mean?
This represents intangible assets, such as iconic brand names or trademarks, that are expected to generate cash flows for an unlimited period. Unlike finite-lived assets, these are not amortized but are tested annually for impairment. They represent the core long-term value of the company's brand portfolio.